1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Memory Enhancement Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Aricept 1.2.3 Razadyne 1.2.4 Namenda 1.2.5 Exelon 1.2.6 Provigil 1.2.7 Ritalin 1.2.8 Adderall 1.2.9 Others 1.3 Market by Application 1.3.1 Global Memory Enhancement Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Disease Treatment 1.3.3 Academic Performance 1.3.4 Athletic Performance 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Memory Enhancement Drugs Market Perspective (2016-2027) 2.2 Memory Enhancement Drugs Growth Trends by Regions 2.2.1 Memory Enhancement Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Memory Enhancement Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Memory Enhancement Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Memory Enhancement Drugs Industry Dynamic 2.3.1 Memory Enhancement Drugs Market Trends 2.3.2 Memory Enhancement Drugs Market Drivers 2.3.3 Memory Enhancement Drugs Market Challenges 2.3.4 Memory Enhancement Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Memory Enhancement Drugs Players by Revenue 3.1.1 Global Top Memory Enhancement Drugs Players by Revenue (2016-2021) 3.1.2 Global Memory Enhancement Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Memory Enhancement Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Memory Enhancement Drugs Revenue 3.4 Global Memory Enhancement Drugs Market Concentration Ratio 3.4.1 Global Memory Enhancement Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Memory Enhancement Drugs Revenue in 2020 3.5 Memory Enhancement Drugs Key Players Head office and Area Served 3.6 Key Players Memory Enhancement Drugs Product Solution and Service 3.7 Date of Enter into Memory Enhancement Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Memory Enhancement Drugs Breakdown Data by Type 4.1 Global Memory Enhancement Drugs Historic Market Size by Type (2016-2021) 4.2 Global Memory Enhancement Drugs Forecasted Market Size by Type (2022-2027) 5 Memory Enhancement Drugs Breakdown Data by Application 5.1 Global Memory Enhancement Drugs Historic Market Size by Application (2016-2021) 5.2 Global Memory Enhancement Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Memory Enhancement Drugs Market Size (2016-2027) 6.2 North America Memory Enhancement Drugs Market Size by Type 6.2.1 North America Memory Enhancement Drugs Market Size by Type (2016-2021) 6.2.2 North America Memory Enhancement Drugs Market Size by Type (2022-2027) 6.2.3 North America Memory Enhancement Drugs Market Size by Type (2016-2027) 6.3 North America Memory Enhancement Drugs Market Size by Application 6.3.1 North America Memory Enhancement Drugs Market Size by Application (2016-2021) 6.3.2 North America Memory Enhancement Drugs Market Size by Application (2022-2027) 6.3.3 North America Memory Enhancement Drugs Market Size by Application (2016-2027) 6.4 North America Memory Enhancement Drugs Market Size by Country 6.4.1 North America Memory Enhancement Drugs Market Size by Country (2016-2021) 6.4.2 North America Memory Enhancement Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Memory Enhancement Drugs Market Size (2016-2027) 7.2 Europe Memory Enhancement Drugs Market Size by Type 7.2.1 Europe Memory Enhancement Drugs Market Size by Type (2016-2021) 7.2.2 Europe Memory Enhancement Drugs Market Size by Type (2022-2027) 7.2.3 Europe Memory Enhancement Drugs Market Size by Type (2016-2027) 7.3 Europe Memory Enhancement Drugs Market Size by Application 7.3.1 Europe Memory Enhancement Drugs Market Size by Application (2016-2021) 7.3.2 Europe Memory Enhancement Drugs Market Size by Application (2022-2027) 7.3.3 Europe Memory Enhancement Drugs Market Size by Application (2016-2027) 7.4 Europe Memory Enhancement Drugs Market Size by Country 7.4.1 Europe Memory Enhancement Drugs Market Size by Country (2016-2021) 7.4.2 Europe Memory Enhancement Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Memory Enhancement Drugs Market Size (2016-2027) 8.2 Asia-Pacific Memory Enhancement Drugs Market Size by Type 8.2.1 Asia-Pacific Memory Enhancement Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Memory Enhancement Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Memory Enhancement Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Memory Enhancement Drugs Market Size by Application 8.3.1 Asia-Pacific Memory Enhancement Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Memory Enhancement Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Memory Enhancement Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Memory Enhancement Drugs Market Size by Region 8.4.1 Asia-Pacific Memory Enhancement Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Memory Enhancement Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Memory Enhancement Drugs Market Size (2016-2027) 9.2 Latin America Memory Enhancement Drugs Market Size by Type 9.2.1 Latin America Memory Enhancement Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Memory Enhancement Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Memory Enhancement Drugs Market Size by Type (2016-2027) 9.3 Latin America Memory Enhancement Drugs Market Size by Application 9.3.1 Latin America Memory Enhancement Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Memory Enhancement Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Memory Enhancement Drugs Market Size by Application (2016-2027) 9.4 Latin America Memory Enhancement Drugs Market Size by Country 9.4.1 Latin America Memory Enhancement Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Memory Enhancement Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Memory Enhancement Drugs Market Size (2016-2027) 10.2 Middle East & Africa Memory Enhancement Drugs Market Size by Type 10.2.1 Middle East & Africa Memory Enhancement Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Memory Enhancement Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Memory Enhancement Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Memory Enhancement Drugs Market Size by Application 10.3.1 Middle East & Africa Memory Enhancement Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Memory Enhancement Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Memory Enhancement Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Memory Enhancement Drugs Market Size by Country 10.4.1 Middle East & Africa Memory Enhancement Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Memory Enhancement Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Memory Enhancement Drugs Introduction 11.1.4 Pfizer Revenue in Memory Enhancement Drugs Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Memory Enhancement Drugs Introduction 11.2.4 Novartis Revenue in Memory Enhancement Drugs Business (2016-2021) 11.2.5 Novartis Recent Development 11.3 Shire Pharmaceuticals 11.3.1 Shire Pharmaceuticals Company Details 11.3.2 Shire Pharmaceuticals Business Overview 11.3.3 Shire Pharmaceuticals Memory Enhancement Drugs Introduction 11.3.4 Shire Pharmaceuticals Revenue in Memory Enhancement Drugs Business (2016-2021) 11.3.5 Shire Pharmaceuticals Recent Development 11.4 Allergan Plc 11.4.1 Allergan Plc Company Details 11.4.2 Allergan Plc Business Overview 11.4.3 Allergan Plc Memory Enhancement Drugs Introduction 11.4.4 Allergan Plc Revenue in Memory Enhancement Drugs Business (2016-2021) 11.4.5 Allergan Plc Recent Development 11.5 Cephalon 11.5.1 Cephalon Company Details 11.5.2 Cephalon Business Overview 11.5.3 Cephalon Memory Enhancement Drugs Introduction 11.5.4 Cephalon Revenue in Memory Enhancement Drugs Business (2016-2021) 11.5.5 Cephalon Recent Development 11.6 AlternaScript 11.6.1 AlternaScript Company Details 11.6.2 AlternaScript Business Overview 11.6.3 AlternaScript Memory Enhancement Drugs Introduction 11.6.4 AlternaScript Revenue in Memory Enhancement Drugs Business (2016-2021) 11.6.5 AlternaScript Recent Development 11.7 Takeda Pharmaceutical Company 11.7.1 Takeda Pharmaceutical Company Company Details 11.7.2 Takeda Pharmaceutical Company Business Overview 11.7.3 Takeda Pharmaceutical Company Memory Enhancement Drugs Introduction 11.7.4 Takeda Pharmaceutical Company Revenue in Memory Enhancement Drugs Business (2016-2021) 11.7.5 Takeda Pharmaceutical Company Recent Development 11.8 Eisai 11.8.1 Eisai Company Details 11.8.2 Eisai Business Overview 11.8.3 Eisai Memory Enhancement Drugs Introduction 11.8.4 Eisai Revenue in Memory Enhancement Drugs Business (2016-2021) 11.8.5 Eisai Recent Development 11.9 Barr Pharmaceuticals 11.9.1 Barr Pharmaceuticals Company Details 11.9.2 Barr Pharmaceuticals Business Overview 11.9.3 Barr Pharmaceuticals Memory Enhancement Drugs Introduction 11.9.4 Barr Pharmaceuticals Revenue in Memory Enhancement Drugs Business (2016-2021) 11.9.5 Barr Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Memory Enhancement Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Aricept Table 3. Key Players of Razadyne Table 4. Key Players of Namenda Table 5. Key Players of Exelon Table 6. Key Players of Provigil Table 7. Key Players of Ritalin Table 8. Key Players of Adderall Table 9. Key Players of Others Table 10. Global Memory Enhancement Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Memory Enhancement Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 12. Global Memory Enhancement Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 13. Global Memory Enhancement Drugs Market Share by Regions (2016-2021) Table 14. Global Memory Enhancement Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 15. Global Memory Enhancement Drugs Market Share by Regions (2022-2027) Table 16. Memory Enhancement Drugs Market Trends Table 17. Memory Enhancement Drugs Market Drivers Table 18. Memory Enhancement Drugs Market Challenges Table 19. Memory Enhancement Drugs Market Restraints Table 20. Global Memory Enhancement Drugs Revenue by Players (2016-2021) & (US$ Million) Table 21. Global Memory Enhancement Drugs Market Share by Players (2016-2021) Table 22. Global Top Memory Enhancement Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Memory Enhancement Drugs as of 2020) Table 23. Ranking of Global Top Memory Enhancement Drugs Companies by Revenue (US$ Million) in 2020 Table 24. Global 5 Largest Players Market Share by Memory Enhancement Drugs Revenue (CR5 and HHI) & (2016-2021) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Memory Enhancement Drugs Product Solution and Service Table 27. Date of Enter into Memory Enhancement Drugs Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Memory Enhancement Drugs Market Size by Type (2016-2021) (US$ Million) Table 30. Global Memory Enhancement Drugs Revenue Market Share by Type (2016-2021) Table 31. Global Memory Enhancement Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 32. Global Memory Enhancement Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 33. Global Memory Enhancement Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 34. Global Memory Enhancement Drugs Revenue Market Share by Application (2016-2021) Table 35. Global Memory Enhancement Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 36. Global Memory Enhancement Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 37. North America Memory Enhancement Drugs Market Size by Type (2016-2021) (US$ Million) Table 38. North America Memory Enhancement Drugs Market Size by Type (2022-2027) & (US$ Million) Table 39. North America Memory Enhancement Drugs Market Size by Application (2016-2021) (US$ Million) Table 40. North America Memory Enhancement Drugs Market Size by Application (2022-2027) & (US$ Million) Table 41. North America Memory Enhancement Drugs Market Size by Country (2016-2021) & (US$ Million) Table 42. North America Memory Enhancement Drugs Market Size by Country (2022-2027) & (US$ Million) Table 43. Europe Memory Enhancement Drugs Market Size by Type (2016-2021) (US$ Million) Table 44. Europe Memory Enhancement Drugs Market Size by Type (2022-2027) & (US$ Million) Table 45. Europe Memory Enhancement Drugs Market Size by Application (2016-2021) (US$ Million) Table 46. Europe Memory Enhancement Drugs Market Size by Application (2022-2027) & (US$ Million) Table 47. Europe Memory Enhancement Drugs Market Size by Country (2016-2021) & (US$ Million) Table 48. Europe Memory Enhancement Drugs Market Size by Country (2022-2027) & (US$ Million) Table 49. Asia-Pacific Memory Enhancement Drugs Market Size by Type (2016-2021) (US$ Million) Table 50. Asia-Pacific Memory Enhancement Drugs Market Size by Type (2022-2027) & (US$ Million) Table 51. Asia-Pacific Memory Enhancement Drugs Market Size by Application (2016-2021) (US$ Million) Table 52. Asia-Pacific Memory Enhancement Drugs Market Size by Application (2022-2027) & (US$ Million) Table 53. Asia-Pacific Memory Enhancement Drugs Market Size by Region (2016-2021) & (US$ Million) Table 54. Asia-Pacific Memory Enhancement Drugs Market Size by Region (2022-2027) & (US$ Million) Table 55. Latin America Memory Enhancement Drugs Market Size by Type (2016-2021) (US$ Million) Table 56. Latin America Memory Enhancement Drugs Market Size by Type (2022-2027) & (US$ Million) Table 57. Latin America Memory Enhancement Drugs Market Size by Application (2016-2021) (US$ Million) Table 58. Latin America Memory Enhancement Drugs Market Size by Application (2022-2027) & (US$ Million) Table 59. Latin America Memory Enhancement Drugs Market Size by Country (2016-2021) & (US$ Million) Table 60. Latin America Memory Enhancement Drugs Market Size by Country (2022-2027) & (US$ Million) Table 61. Middle East & Africa Memory Enhancement Drugs Market Size by Type (2016-2021) (US$ Million) Table 62. Middle East & Africa Memory Enhancement Drugs Market Size by Type (2022-2027) & (US$ Million) Table 63. Middle East & Africa Memory Enhancement Drugs Market Size by Application (2016-2021) (US$ Million) Table 64. Middle East & Africa Memory Enhancement Drugs Market Size by Application (2022-2027) & (US$ Million) Table 65. Middle East & Africa Memory Enhancement Drugs Market Size by Country (2016-2021) & (US$ Million) Table 66. Middle East & Africa Memory Enhancement Drugs Market Size by Country (2022-2027) & (US$ Million) Table 67. Pfizer Company Details Table 68. Pfizer Business Overview Table 69. Pfizer Memory Enhancement Drugs Product Table 70. Pfizer Revenue in Memory Enhancement Drugs Business (2016-2021) & (US$ Million) Table 71. Pfizer Recent Development Table 72. Novartis Company Details Table 73. Novartis Business Overview Table 74. Novartis Memory Enhancement Drugs Product Table 75. Novartis Revenue in Memory Enhancement Drugs Business (2016-2021) & (US$ Million) Table 76. Novartis Recent Development Table 77. Shire Pharmaceuticals Company Details Table 78. Shire Pharmaceuticals Business Overview Table 79. Shire Pharmaceuticals Memory Enhancement Drugs Product Table 80. Shire Pharmaceuticals Revenue in Memory Enhancement Drugs Business (2016-2021) & (US$ Million) Table 81. Shire Pharmaceuticals Recent Development Table 82. Allergan Plc Company Details Table 83. Allergan Plc Business Overview Table 84. Allergan Plc Memory Enhancement Drugs Product Table 85. Allergan Plc Revenue in Memory Enhancement Drugs Business (2016-2021) & (US$ Million) Table 86. Allergan Plc Recent Development Table 87. Cephalon Company Details Table 88. Cephalon Business Overview Table 89. Cephalon Memory Enhancement Drugs Product Table 90. Cephalon Revenue in Memory Enhancement Drugs Business (2016-2021) & (US$ Million) Table 91. Cephalon Recent Development Table 92. AlternaScript Company Details Table 93. AlternaScript Business Overview Table 94. AlternaScript Memory Enhancement Drugs Product Table 95. AlternaScript Revenue in Memory Enhancement Drugs Business (2016-2021) & (US$ Million) Table 96. AlternaScript Recent Development Table 97. Takeda Pharmaceutical Company Company Details Table 98. Takeda Pharmaceutical Company Business Overview Table 99. Takeda Pharmaceutical Company Memory Enhancement Drugs Product Table 100. Takeda Pharmaceutical Company Revenue in Memory Enhancement Drugs Business (2016-2021) & (US$ Million) Table 101. Takeda Pharmaceutical Company Recent Development Table 102. Eisai Company Details Table 103. Eisai Business Overview Table 104. Eisai Revenue in Memory Enhancement Drugs Business (2016-2021) & (US$ Million) Table 105. Eisai Recent Development Table 106. Barr Pharmaceuticals Company Details Table 107. Barr Pharmaceuticals Business Overview Table 108. Barr Pharmaceuticals Memory Enhancement Drugs Product Table 109. Barr Pharmaceuticals Revenue in Memory Enhancement Drugs Business (2016-2021) & (US$ Million) Table 110. Barr Pharmaceuticals Recent Development Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Global Memory Enhancement Drugs Market Share by Type: 2020 VS 2027 Figure 2. Aricept Features Figure 3. Razadyne Features Figure 4. Namenda Features Figure 5. Exelon Features Figure 6. Provigil Features Figure 7. Ritalin Features Figure 8. Adderall Features Figure 9. Others Features Figure 10. Global Memory Enhancement Drugs Market Share by Application: 2020 VS 2027 Figure 11. Disease Treatment Case Studies Figure 12. Academic Performance Case Studies Figure 13. Athletic Performance Case Studies Figure 14. Others Case Studies Figure 15. Memory Enhancement Drugs Report Years Considered Figure 16. Global Memory Enhancement Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 17. Global Memory Enhancement Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 18. Global Memory Enhancement Drugs Market Share by Regions: 2020 VS 2027 Figure 19. Global Memory Enhancement Drugs Market Share by Regions (2022-2027) Figure 20. Global Memory Enhancement Drugs Market Share by Players in 2020 Figure 21. Global Top Memory Enhancement Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Memory Enhancement Drugs as of 2020 Figure 22. The Top 10 and 5 Players Market Share by Memory Enhancement Drugs Revenue in 2020 Figure 23. Global Memory Enhancement Drugs Revenue Market Share by Type (2016-2021) Figure 24. Global Memory Enhancement Drugs Revenue Market Share by Type (2022-2027) Figure 25. North America Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. North America Memory Enhancement Drugs Market Share by Type (2016-2027) Figure 27. North America Memory Enhancement Drugs Market Share by Application (2016-2027) Figure 28. North America Memory Enhancement Drugs Market Share by Country (2016-2027) Figure 29. United States Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Canada Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Europe Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Europe Memory Enhancement Drugs Market Share by Type (2016-2027) Figure 33. Europe Memory Enhancement Drugs Market Share by Application (2016-2027) Figure 34. Europe Memory Enhancement Drugs Market Share by Country (2016-2027) Figure 35. Germany Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. France Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. U.K. Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Italy Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Russia Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Nordic Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Asia-Pacific Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Asia-Pacific Memory Enhancement Drugs Market Share by Type (2016-2027) Figure 43. Asia-Pacific Memory Enhancement Drugs Market Share by Application (2016-2027) Figure 44. Asia-Pacific Memory Enhancement Drugs Market Share by Region (2016-2027) Figure 45. China Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Japan Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. South Korea Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Southeast Asia Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. India Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Australia Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Latin America Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Latin America Memory Enhancement Drugs Market Share by Type (2016-2027) Figure 53. Latin America Memory Enhancement Drugs Market Share by Application (2016-2027) Figure 54. Latin America Memory Enhancement Drugs Market Share by Country (2016-2027) Figure 55. Mexico Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Brazil Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Middle East & Africa Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Middle East & Africa Memory Enhancement Drugs Market Share by Type (2016-2027) Figure 59. Middle East & Africa Memory Enhancement Drugs Market Share by Application (2016-2027) Figure 60. Middle East & Africa Memory Enhancement Drugs Market Share by Country (2016-2027) Figure 61. Turkey Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Saudi Arabia Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. UAE Memory Enhancement Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 64. Pfizer Revenue Growth Rate in Memory Enhancement Drugs Business (2016-2021) Figure 65. Novartis Revenue Growth Rate in Memory Enhancement Drugs Business (2016-2021) Figure 66. Shire Pharmaceuticals Revenue Growth Rate in Memory Enhancement Drugs Business (2016-2021) Figure 67. Allergan Plc Revenue Growth Rate in Memory Enhancement Drugs Business (2016-2021) Figure 68. Cephalon Revenue Growth Rate in Memory Enhancement Drugs Business (2016-2021) Figure 69. AlternaScript Revenue Growth Rate in Memory Enhancement Drugs Business (2016-2021) Figure 70. Takeda Pharmaceutical Company Revenue Growth Rate in Memory Enhancement Drugs Business (2016-2021) Figure 71. Eisai Revenue Growth Rate in Memory Enhancement Drugs Business (2016-2021) Figure 72. Barr Pharmaceuticals Revenue Growth Rate in Memory Enhancement Drugs Business (2016-2021) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed

Pfizer Novartis Shire Pharmaceuticals Allergan Plc Cephalon AlternaScript Takeda Pharmaceutical Company Eisai Barr Pharmaceuticals